RP Bio

RP Bio is a leading South Korean pharmaceutical company specializing in the development and manufacturing of soft capsules for the pharmaceutical and health functional food industries. Founded in 1983 as a joint venture between Daewoong Pharmaceutical and the American company R.P. Scherer, it has established itself as a dominant player in the domestic soft capsule market. The company operates as a Contract Development and Manufacturing Organization (CDMO), providing end-to-end services from formulation to commercial production. RP Bio leverages proprietary technologies, such as the Neosol platform, to enhance the stability, solubility, and bioavailability of active pharmaceutical ingredients. Its product portfolio includes a wide range of over-the-counter medications, vitamins, and nutritional supplements. The company is publicly traded on the KOSDAQ exchange and serves a diverse client base across global healthcare markets.